Blood-brain barrier for human growth hormone and insulin-like growth factor-I

Journal of Pediatric Endocrinology and Metabolism

Volumn 12, Issue 2, 1999, Pages 113-124

  Coculescu, Mihail ^a,b  

^a C I PARHON NATIONAL INSTITUTE OF ENDOCRINOLOGY   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Blood brain barrier; Cerebrospinal fluid; Growth hormone receptors; Human growth hormone; Insulin like growth factors

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; BRAIN DEVELOPMENT; CEREBROSPINAL FLUID LEVEL; CHOROID PLEXUS; CLINICAL TRIAL; FEEDBACK SYSTEM; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE TRANSPORT; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; RECEPTOR DENSITY; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSCYTOSIS; ULTRADIAN RHYTHM;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CATS; FEMALE; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; NEUROGLIA; NEURONS; NEUROTRANSMITTER AGENTS; POULTRY; RATS; RECEPTORS, SOMATOTROPIN; SOMATOMEDINS;

EID: 0032942159     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1999.12.2.113     Document Type: Review

References (82)

1. Begley DJ. Peptides and the blood-brain barrier. In: Bradbury MWB, ed. Physiology and Pharmacology of the Blood-Brain Barrier. Berlin-Heidelberg-New York: Springer-Verlag 1992; 151-203.
2. Dagerblad M, Almkvist O, Grunditz R, Hall K, Kaijser L, Knutsson E, Ringertz H, Thoren M. Physical and psychological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency. Acta Endocrinol (Kbh) 1990; 123: 185-193.
3. McGauley GA, Cuneo RC, Salomon F, Sonksen PH. Psychological wellbeing before and after GH treatment in adults with GH deficiency. Horm Res 1990; 33 (Suppl 4): 52-54.
4. Bengtsson BA, Eden S, Lohn L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Tolli J, Sjostrom L, Isaksson O. Treatment of adults with GH deficiency with recombinant human growth hormone. J Clin Endocrinol Metab 1993; 76: 309-317.
5. Deijen JB, DeBoer H, van der Veen EA. Growth hormone treatment in adults: psychological wellbeing and cognitive functioning. Endocrinol Metab 1997; 4: 109-111.
6. Andersson K, Fuxe K, Eneroth P, Isarsson O, Nyberg S, Roos P. Rat GH and hypothalamic catecholamine nerve terminal systems. Evidence for rapid and direct reduction in dopamine and noradrenaline levels and turnover in the median eminence of the hypophysectomized male rat. Eur J Pharmacol 1983; 95: 271-275.
7. Burman P, Hetta J, Karlsson A. Effect of GH on brain neurotransmitters. Lancet 1993; 342: 1492-1493.
8. Johansson J-O, Larson N, Andersson M, Elmgren A, Hynsjo L, Lindhal A, Isaksson OGB, Lindstedt S, Bengtsson B-A.Treatment of growth hormone (GH)-deficient adults with recombinant human GH increases the concentration of GH in the cerebrospinal fluid and affects the neurotransmitters. Neuroendocrinology 1995; 61: 57-66.
9. Burman P, Hetta J, Wide L, Mansson JE, Ekman R, Karlsson FA. Growth hormone treatment affects brain neurotransmitters and thyroxine. Clin Endocrinol (Oxf) 1996; 44: 319-324.
10. Linfoot JA, Garcia JF, Wei W, Fink R, Sarin R, Born JL, Lawrence JH. Human growth hormone levels in cerebrospinal fluid. J Clin Endocrinol Metab 1970; 31: 230-232.
11. Hull KL, Harvey S. Autoregulation of central and peripheral growth hormone receptor. J Endocrinol 1998; 156: 323-329.
12. Lai ZN, Emtner M, Roos P, Nyberg F. Characterization of putative growth hormone receptors in human choroid plexus. Brain Res 1991; 546: 222-226.
13. Nyberg F, Burman P. Growth hormone and its receptors in the central nervous system - location and functional significance. Horm Res 1996; 45: 18-22.
14. Lobie PE, Garcia-Aragon J, Lincoln DT, Barnard R, Wilcox JN, Waters MJ. Localization and ontogeny of growth hormone receptor gene expression in the central nervous system. Brain Res Dev 1993; 74: 225-233.
15. Hojvat S, Baker G, Kirsteins L, Lawrence AM. Growth hormone immunoreactivity in the rodent and primate CNS: distribution, characterization and presence posthypophysectomy. Brain Res 1982; 239: 543-547.
16. Brightman MW. Ultrastructure of brain endothelium. In: Bradbury MWB, ed. Physiology and Pharmacology of the Blood-Brain Barrier. Berlin-Heidelberg-New York: Springer-Verlag, 1992; 151-203.
17. Sternberger NW, Sternberger LA. Blood-brain barrier protein recognized by monoclonal antibody. Proc Natl Acad Sci USA 1987; 84: 8169-8173.
18. Simionescu M, Simionescu N, Palade GE. Morphometric data on the endothelium of blood capillaries. J Cell Biol 1974; 60: 128-152.
19. Greig NH. Drug entry into the brain and its pharmacologic manipulation. In: Bradbury MWB, ed. Physiology and Pharmacology of the Blood-Brain Barrier. Berlin-Heidelberg-New York: Springer-Verlag, 1992; 151-203.
20. Pardridge WM. Receptor-mediated peptide transport through the blood-brain barrier. Endocr Rev 1986; 7: 314-330.
21. Pardridge WM, Eisenberg J, Cefalu WT. Absence of albumin receptor on brain capillaries in vivo or in vitro. Am J Physiol 1985; 249: T264-T267.
22. Simionescu M, Ghinea N, Fixman A, Lasser M, Kukes L, Simionescu N, Palade GE. The cerebral microvasculature of the rat: structure and luminal surface properties during early development. J Submicrosc Cytol Pathol 1988; 20: 243-261.
23. Coculescu M. Clinical Neuroendocrinology. Bucharest: Scientific & Encyclopedic Publ. House, 1986; 173-203 (in Rumanian).
24. Cserr HF, Patlak CS. Secretion and bulk flow of interstitial fluid. In: Bradbury MWB, ed. Physiology and Pharmacology of the Blood-Brain Barrier. Berlin-Heidelberg-New York: Springer-Verlag, 1992; 151-203.
25. Underwood LE. Short stature. In: Bardin CW, ed. Current Therapy in Endocrinology and Metabolism. St Louis-Baltimore-Boston: Mosby, 1997; 66-67.
26. Zamenhof S, Mosley J, Schuller E. Stimulation of the proliferation of cortical neurons by prenatal treatment with growth hormone. Science 1966; 152: 1396-1397.
27. Sara V, Lazarus L. The prenatal action of GH on brain and behavior. Nature 1974; 250: 257-258.
28. Laron Z, Lazar L, Galatzer A, Pertzelan A. Growth hormone treatment accelerates head circumference growth in isolated GH deficiency. In: Hauspie R, Lindgren G, Falkner F, eds. Essays on Auxology. Hertfordshire, U.K.: Castlemead Publications, 1995; 489-495.
29. Laron Z, Anin S, Klipper-Aubach Y, Klinger B. Effects of insulin-like growth factor on linear growth, head circumference and body fat in patients with Laron-type dwarfism. Lancet 1992; 339: 1258-1261.
30. Rosen T, Johansson G, Bengtsson BA. Consequences of GH deficiency in adults, and effects of GH replacement therapy. Acta Paediatr Scand 1994; Suppl 399: 21-24.
31. Astrom C, Pedersen SA, Lindholm J. The influence of GH on sleep in adults with growth hormone deficiency. Clin Endocrinol 1990; 33: 496-500.
32. Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sonksen PH, Tanaka T, Thorner M. Growth hormone deficiency in adulthood and the effects of growth hormone replacement. A review. J Clin Endocrinol Metab 1998; 83: 382-395.
33. Whitehead HM, Boreham C, McIlrath EM, Sheridan E, Kennedy L, Atkinson AB, Hadden DR. Growth hormone treatment of adults with GH deficiency: results of a 13-month placebo controlled cross-over study. Clin Endocrinol 1992; 36: 45-52.
34. Florkowski CM, Stevens I, Joyce P, Espiner EA, Donald RA. Growth hormone replacement does not improve psychological well-being in adult hypopituitarism: a randomized crossover trial. Psycho-neuroendocrinology 1998; 23: 57-63.
35. Verbels J, Abs R, Vandeweghe M, Mockel J, Legros JJ, Copinschi G, Mahler C, Velkeniers B, Vanhaelst L, Van Aelest A, De Rijdt D, Stevenaert A, Beckers A. Two years of replacement therapy in adults with GH deficiency. Clin Endocrinol 1997; 47: 485-494.
36. Burman P, Broman JE, Hetta J, Wiklund I, Erfurth EM, Hagg E, Karlsson FA. Quality of life in adults with GH deficiency: response to treatment with recombinant human GH in a placebo controlled 21-month trial. J Clin Endocrinol Metab 1995; 80: 3585-3590.
37. Papadakis MA, Grady D, Black D, Tierney MJ, Gooding GA, Schambelan M, Grunfeld C. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med 1996; 124: 708-716.
38. Sartorio A, Conti A, Molinari E, Riva G, Morabito F, Faglia G. Growth, growth hormone and cognitive functions. Horm Res 1996; 45: 23-29.
39. Sandberg DE, Macgillivray MH, Clopper RR, Fung C, LeRoux L, Alliger DE. Quality of life among formerly treated childhood onset growth hormone deficient adults: a comparison with unaffected siblings. J Clin Endocrinol Metab 1998; 83: 1134-1142.
40. Laron Z. Disorders of GH resistance in childhood. Curr Opin Pediatr 1993; 5: 474-480.
41. Ross JL, Feuillan P, Kushner H, Roeltgen D, Cutler GB Jr. Absence of GH effects on cognitive function in girls with Turner syndrome. J Clin Endocrinol Metab 1997; 82: 1814-1817.
42. Stern WC, Miller M, Jalowiec JE, Forbes WB, Morgane PJ. Effects of growth hormone on brain biogenic amine levels. Pharmacol Biochem Behav 1975; 3: 1115-1118.
43. Konishi M. Brain and behavior. In: Boyd CAR, Noble D. The Logic of Life. The Challenge of Integrative Physiology. Oxford-New York-Tokyo: Oxford University Press, 1993; 169-188.
44. 125I-labeled rat growth hormone in regional brain areas and peripheral tissue of the rat. Am J Anat 1975; 144: 503-507.
45. Zhai Q, Lai ZN, Roos P, Nyberg F. Characterization of GH binding sites in rat brain. Acta Paediatr 1994; Suppl 406: 92-95.
46. Grigorescu FL, Coculescu M, Dimitriu V, Iager AC. Blood-cerebrospinal fluid barrier for human growth hormone. Neurol Psychiatr (Bucharest) 1978; 16: 33-36.
47. Belchetz PE, Ridley RM, Baker HF. Studies on the accessibility of prolactin and growth hormone to brain: effect of opiate agonists on hormone levels in serial simultaneous plasma and cerebrospinal fluid samples in the rhesus monkey. Brain Res 1982; 239: 310-314.
48. Coculescu M, Poiana C, Pop A, Oprescu M, Constantinovici A, Simionescu N. Altered specificity of the blood-cerebrospinal fluid barrier for pituitary hormones in patients with tumoral hypothalamo-hypophyseal diseases as proved by releasing hormone stimulation. Rev Roum Physiologie 1985; 22: 269-292.
49. Coculescu M, Cucu C, Catrina SB, Ioachimescu A, Caragheorgheopol A, Fleseriu M, Vatasescu R, Carnu R, Badiu C. The blood-brain barrier permeability by human growth hormone (hGH) as reflected by hGH concentration in cerebrospinal fluid. J Endocrinol 1998; Suppl 159. OC22 (abstr).
50. Coculescu M, Simionescu L, Constantinovici AL, Login S, Simionescu N, Dimitriu V, Oprescu M, Grigorescu F. High level of human growth hormone in cerebrospinal fluid of patients with pituitary tumors. Rev Roum Endocrinol 1979; 17: 205-211.
51. Coculescu M, Temeli E, Oprescu M, Simionescu N. High permeability of blood-cerebrospinal fluid barrier for prolactin in patients with invasive prolactinomas. International Rapid Communication System, Medical Sciences 1982; 10: 1029.
52. Coculescu M, Temeli E, Oprescu M, Dimitriu V, Simionescu N. Blood-cerebrospinal fluid barrier for prolactin in empty sella syndrome. Rev Roum Endocrinol 1981; 19: 129-206.
53. Iranmanesh A, South S, Liem AY, Clemmons D, Thorner MO, Weltman A, Veldhuis JD. Unequal impact of age, percentage body fat and serum testosterone concentrations on the somatotropic, IGF-I and IGF-GB responses to a three day iv GH-RH pulsatile infusion in man. Eur J Endocrinol 1998; 139: 59-71.
54. Reichlin S. Neuroendocrinology. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Williams Textbook of Endocrinology. Philadelphia-London-Toronto: WB Saunders Co., 1998; 165-206.
55. Kelly PA, Djane J, Postel-Vinay MC, Edery M. The prolactin/growth hormone receptor family. Endocr Rev 1991; 12: 235-251.
56. Han VKM. Is the central nervous system a target for growth hormone and insulin-like growth factors? Acta Paediatr 1995; Suppl 411: 3-8.
57. Herington AC. New frontiers in the molecular mechanisms of growth hormone action. Mol Cell Endocrinol 1994; 100: 39-44.
58. Lai Z, Roos P, Zhai Q, Olsson Y, Fholenhag K, Larsson C, Nyberg F. Age related reduction of hGH binding sites in the human brain. Brain Res 1993; 621: 260-266.
59. Nyberg F. Aging effects on growth hormone receptor binding in the brain. Exp Gerontol 1997; 32: 521-528.
60. Burton KA, Kabingting EB, Clifton DK, Steiner RA. Growth hormone receptor mRNA distribution in the adult male rat brain and its co-localization in hypothalamic somatostatin neurons. Endocrinology 1992; 130: 958-963.
61. Chan YY, Steiner RA, Clifton DK. Regulation of hypothalamic neuropeptide-Y neurons by growth hormone in the rat. Endocrinology 1996; 137: 1319-1325.
62. Kamegai J, Minami S, Sugihara H, Hasegawa O, Higuchi H, Wakabavashi I. Growth hormone receptor gene is expressed in neuropeptide-Y neurons in hypothalamic arcuate nucleus of rats. Endocrinology 1996; 137: 2109-2112.
63. Zhai Q, Lai ZN, Yukhananov R, Roos P, Nyberg F. Decreased binding of GH in rat hypothalamus and choroid plexus following morphine treatment. Neurosci Lett 1995; 184: 82-85.
64. Pellegrini E, Bluet-Pajot MT, Mounier F, Bennett P, Kordon C, Epelbaum J. Central administration of GH receptor mRNA antisense increases GH pulsatility and decreases hypothalamic somatostatin expression in rats. J Neurosci 1996; 16: 8140-8148.
65. Pihoker C, Kearns GL, French D, Bowers CY. Pharmakokinetics and pharmacodynamics of growth hormone-releasing peptide 2: a phase I study in children. J Clin Endocrinol Metab 1998; 83: 1168-1172.
66. Reinhardt RR, Bondy CA. Insulin-like growth factors cross the blood-brain barrier. Endocrinology 1994; 135: 1753-1761.
67. Laron Z, Lazar L, Klinger B. Growth hormone, insulin-like growth factor I and brain growth and function. In: Castells S, Wisniewski JL, eds. Growth Hormone Treatment in Down's Syndrome. Chichester: John Wiley and Sons, 1993; 151-161.
68. Backstrom M, Hall K, Sara V. Somatomedin levels in CSF from adults with pituitary disorders. Acta Endocrinol (Kbh) 1984; 107: 171-178.
69. Carlsson-Skwirut C, Jornvall H, Holmgren A. Isolation and characterization of variant IGF-I as well as IGF-II from adult human brain. FEBS Lett 1986; 201: 46-50.
70. Sara V, Carlsson-Skwirut C, Andersson C. Characterization of somatomedins from human fetal brain: identification of a variant form of IGF-I. Proc Natl Acad Sci USA 1986; 83: 4904-4907.
71. Rosenfeld RG, Pham H, Keller BT, Borchardt RT, Pardridge WM. Demonstration and structural comparison of receptors for insulin-like growth factor-I and -II in brain and blood-brain barrier. Biochem Biophys Res Comm 1987; 149: 159-166.
72. Garcia-Segura LM, Rodrigues JR, Torres-Aleman I. Localization of the insulin-like growth factor I receptor in the cerebellum and hypothalamus of adult rats: an electron microscopic study. J Neurocytol 1997; 26: 479-490.
73. Quiroga S, Garofalo RS, Pfenninger KH. Insulin-like growth factor I receptors of fetal brain are enriched in nerve growth cones and contain a beta-subunit variant. Proc Natl Acad Sci USA 1995; 92: 4309-4312.
74. Dore S, Kar S, Quirion R. Presence and differential internalization of two distinct insulin-like growth factor receptors in rat hippocampal neurons. Neuroscience 1997; 78: 373-383.
75. Logan A, Gonzalez AM, Hill DJ, Berry M, Gregson NA, Baird A. Coordinated pattern of expression and localization of IGF-II and IGF-BP2 in the adult rat brain. Endocrinology 1994; 135: 2255-2264.
76. Jones JI, Clemmons DC. IGF and their binding proteins: biological actions. Endocr Rev 1995; 16: 3-34.
77. Carsson MJ, Behringer RR Brinster R, McMorris FA. IGF-I increases brain growth and central nervous system myelination in transgenic mice. Neuron 1993; 10: 729-740.
78. D'Ercole AJ, Dai Z, Xing Y. Brain growth retardation due to the expression of human IGF-BP 1 in transgenic mice; an in vivo model for the analysis of IGF function in the brain. Dev Brain Res 1994; 82: 212-222.
79. Liu JP, Baker J, Perkins AS, Robertsson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding IGF-I and type 1 IGF receptors. Cell 1993; 75: 73-82.
80. Mustafa A, Nyberg F, Bogdanovic N, Islam A, Roos P, Adem A. Somatogenic and lactogenic binding sites in rat brain and liver. Neurosci Res 1994; 20: 257-263.
81. Hojvat S, Emanuele N, Baker G, Connick E, Kirsteins L, Lawrence AM. GH, TSH and LH-like peptides in the rodent brain: non-parallel ontogenetic development with pituitary counterparts. Dev Brain Res 1982; 4: 427-434.
82. Gossar F, Dihl F, Pelletier G, Tubois PM, Morel G. In situ hybridization to rat brain and pituitary gland of GH cDNA. Neurosci Lett 1987; 79: 251-256.